FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emanuel Jacky

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Thomas Pabst; Jakob Passweg; Harry C Schouten; Peter Sonneveld; Matthias Theobald; Wim van Putten; Marie-Christiane Vekemans; Edo Vellenga; Leo Verdonck; Mario Bargetzi; Bart Biemond; Carlos Graux; Emanuel Jacky; Marie-Cecile Legdeur; Bob Löwenberg; Johan Maertens; Gert Jan Ossenkoppele
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.
Sibylle Kohler; Emanuel Jacky; Oliver Tschopp; Christoph Schmid
Paraneoplastic hyperthyroidism.
Jan J Cornelissen; Wim L J van Putten; Leo F Verdonck; Matthias Theobald; Emanuel Jacky; S M G J Daenen; Marinus van Marwijk Kooy; Pierre W Wijermans; Harry Schouten; Peter C Huijgens; Hans van der Lelie; Martin Fey; Augustin Ferrant; Johan Maertens; Alois Gratwohl; Bob Lowenberg
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emanuel Jacky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Thomas Pabst; Jakob Passweg; Harry C Schouten; Peter Sonneveld; Matthias Theobald; Wim van Putten; Marie-Christiane Vekemans; Edo Vellenga; Leo Verdonck; Mario Bargetzi; Bart Biemond; Carlos Graux; Emanuel Jacky; Marie-Cecile Legdeur; Bob Löwenberg; Johan Maertens; Gert Jan Ossenkoppele
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.
Blood 2012;119(23):5367-73.
2011: Sibylle Kohler; Emanuel Jacky; Oliver Tschopp; Christoph Schmid
Paraneoplastic hyperthyroidism.
BMJ case reports 2011;2011():.
2007: Jan J Cornelissen; Wim L J van Putten; Leo F Verdonck; Matthias Theobald; Emanuel Jacky; S M G J Daenen; Marinus van Marwijk Kooy; Pierre W Wijermans; Harry Schouten; Peter C Huijgens; Hans van der Lelie; Martin Fey; Augustin Ferrant; Johan Maertens; Alois Gratwohl; Bob Lowenberg
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Blood 2007;109(9):3658-66.
2005: Dimitri A Breems; Wim L J van Putten; Peter C Huijgens; Gert Ossenkoppele; Gregor Verhoef; Leo F Verdonck; Edo Vellenga; Georgine E De Greef; Emanuel Jacky; Johannes Van Der Lelie; Marc Boogaerts; Bob Löwenberg
Prognostic index for adult patients with acute myeloid leukemia in first relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1969-78.
2005: Georgine E De Greef; Wim L J van Putten; Marc Boogaerts; Peter C Huijgens; Leo F Verdonck; Edo Vellenga; Matthias Theobald; Emanuel Jacky; Bob Löwenberg
Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies.
British journal of haematology 2005;128(2):184-91.
2004: Valérie Beyer; Chantal Castagné; Dominique Mühlematter; Valérie Parlier; Jürg Gmür; Urs Hess; Tibor J Kovacsovics; Sandrine Meyer-Monard; André Tichelli; Andreas Tobler; Emanuel Jacky; Urs Schanz; Mario Bargetzi; Anne Hagemeijer; Theo de Witte; Guy van Melle; Martine Jotterand
Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
Cancer genetics and cytogenetics 2004;152(1):29-41.
2004: Adrian Dubs; Emanuel Jacky; Rolf Stahel; Christian Taverna; Hanspeter Honegger
Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1158; author reply 1158-9.
2004: Monika Jermann; LM Jost; Christian Taverna; Emanuel Jacky; Hanspeter Honegger; Daniel C Betticher; Fritz Egli; Th Kroner; Rolf A Stahel
Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):511-6.
2004: Andreas Trojan; Helen I Joller-Jemelka; Rolf A Stahel; Emanuel Jacky; Martin Hersberger
False-positive human serum chorionic gonadotropin in a patient with a history of germ cell cancer.
Oncology 2004;66(4):336-8.
2003: Andreas Trojan; Emanuel Jacky; F Follath; R Dummer
Necrolytic migratory erythema (glucagenoma)-like skin lesions induced by EGF-receptor inhibition.
Swiss medical weekly 2003;133(1-2):22-3.
2002: Rudolf Morant; Shu-Fang Hsu Schmitz; Jürg Bernhard; Beat Thürlimann; Markus M Borner; Marion Wernli; Fritz Egli; P Forrer; A Streit; Emanuel Jacky; Silvia Hanselmann; J Bauer; Franz Hering; Hans-Peter Schmid
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study.
European journal of cancer (Oxford, England : 1990) 2002;38(12):1626-32.
2000: G Tscherry; Emanuel Jacky; LM Jost; Rolf A Stahel
Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Oncology 2000;59(2):110-7.
2000: Rudolf Morant; Jürg Bernhard; Rudolf Maibach; Markus M Borner; Martin F Fey; Beat Thürlimann; Emanuel Jacky; Felix B Trinkler; J Bauer; G Zulian; Silvia Hanselmann; Christoph Hürny; Franz Hering
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):183-8.
1999: Rolf A Stahel; LM Jost; Th Kroner; Corina Dommann-Scherrer; Robert Maurer; Christoph Glanzmann; Emanuel Jacky; Gabriella Pichert; Bernhard C Pestalozzi; B Marincek; C Sauter; Hanspeter Honegger
A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission.
British journal of haematology 1999;104(4):763-9.
1998: Christian Taverna; Emanuel Jacky; C Sauter
[Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
Schweizerische medizinische Wochenschrift 1998;128(27-28):1117.
1998: C Sauter; Emanuel Jacky
Images in clinical medicine. Chloroma in acute myelogenous leukemia.
The New England journal of medicine 1998;338(14):969.
1997: B C Pestalozzi; G P Krestin; Urs Schanz; Emanuel Jacky; Jürg Gmür
Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia.
Blood 1997;90(10):3858-64.
1997: Markus Fopp; Martin F Fey; M Bacchi; F Cavalli; J Gmuer; Emanuel Jacky; L Schmid; André Tichelli; Andreas Tobler; L Tschopp; V Von Fliedner; Alois Gratwohl
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(3):251-7.
1996: E Christ; A Linka; Emanuel Jacky; R Speich; B Marincek; A Schaffner
Sweet's syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid.
Leukemia 1996;10(4):731-4.
1995: LM Jost; Emanuel Jacky; C Dommann-Scherrer; Hanspeter Honegger; R Maurer; C Sauter; Rolf A Stahel
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(5):445-51.
1994: Rolf A Stahel; LM Jost; T Cerny; Gabriella Pichert; Hanspeter Honegger; A Tobler; Emanuel Jacky; M Fey; E Platzer
Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1931-8.
1994: M Wernli; André Tichelli; V von Fliedner; G Brun del Re; B Chapuis; Martin F Fey; Markus Fopp; J Gmür; J P Grob; Emanuel Jacky
Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. Working Party on Leukaemia of the Swiss Group for Epidemiologic and Clinical Cancer Research (SAKK).
British journal of haematology 1994;87(1):39-43.
1993: LM Jost; Gabriella Pichert; M Reichlin; E Müller; Emanuel Jacky; Hanspeter Honegger; Jürg Gmür; Rolf A Stahel
[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence].
Schweizerische medizinische Wochenschrift 1993;123(18):932-40.